Insider trades
Rekha Hemrajani, Director of Maxcyte MXCT, has filed 2 purchases and 1 sale on the open market. The latest trade was on 06/17.
Rekha Hemrajani
Director
- Company
- Maxcyte MXCT
- First filing
- 23/03/21
- Trades
- 21 trades
- Buys / sales
- 2 / 1
- 12-month net buying
- No record
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MaxcyteMXCT | Open-market sale10b5-1 plan | 25/06/25 | 25/08/27 | 10,684 sh | $2.09 | $22,329.56 | −21.1% |
BioAge LabsBIOA | Open-market buyAmendment | 24/09/27 | 25/03/10 | 3,000 sh | $18.00 | $54,000 | No record |
| Open-market buy | 24/12/02 | 24/12/04 | 30,000 sh | $1.55 | $46,500 | +1000.0% |
